Posts Tagged ‘executive compensation’
Study: Deferred Comp Boosts Ethics
We have a fresh bit of ethics and compliance academic research to start our week: a study from Australia demonstrating that deferred compensation is indeed a good way to curb misconduct risk among employees — and can even boost employee productivity, too. The study comes from Elizabeth Sheedy, business professor at Macquarie University and director…
Read MoreCalculating the Pay Ratio Rule
A new study shows that CEOs still make gobs more money than the rest of us mere mortals, although Corporate America uses a variety of approaches to demonstrate that point. ClearBridge Compensation Group analyzed 100 companies in the S&P 500 to see how they complied with the CEO Pay Ratio Disclosure Rule. That’s the requirement…
Read MoreSEC Talks Culture, Kinda Misses Key Point
The Securities and Exchange Commission has been talking up the importance of corporate culture lately, including two speeches already this week that touch on the subject. Corporate compliance officers trying to glean insights about what to tell your own boards about culture may want to take a closer look — especially to understand a crucial…
Read MoreMore Thoughts on the Misconduct Penalty
My previous post about the salary penalty for people who have “tainted” companies on their resume has generated quite a bit of attention, and rightly so. That penalty — a haircut of 4 to 10 percent off the salary of your next job — says a lot about how people instinctively respond to perceptions of…
Read MoreThe Salary Penalty for Misconduct
Here’s yet another way to convince senior executives and other colleagues that a strong compliance program matters: misconduct at the company can trim the salary offer those people might get at their next job — by 4.6 percent or more, apparently. So says a fascinating paper from Harvard Business School, where two professors examined a…
Read MoreCompliance Lessons in Cardinal Governance Fight
We have an update to that corporate governance drama at Cardinal Health, where the Teamsters were trying to strip the CEO of his role as board chairman, and cited excessive pay to the company’s chief compliance officer as evidence of poor leadership. Their campaign worked. Granted, their shareholder proposal failed to win a majority at…
Read MoreTeamsters Blast Cardinal Health Compliance Efforts
The Teamsters’ Union is pressuring Cardinal Health to separate the CEO and board chairman roles at the company—and cites large bonus pay to Cardinal’s top compliance officer as one sign of misgovernance. The Teamsters made their campaign public last week, with a letter to Cardinal investors urging them to support a shareholder proposal for an…
Read MoreRisky Talk: Compliance Officers and CEO Pay
Should the chief compliance officer have a role in setting executive pay? That was a big question asked at the Society of Corporate Compliance & Ethics annual conference this week. You couldn’t escape the subject. More than 1,700 compliance professionals had gathered to talk about good corporate conduct, and we had examples of bad corporate conduct…
Read MoreAnother Governance Problem Mylan Calls Out
For corporate governance and compliance thinkers, Mylan Labs is the gift that keeps on giving. Earlier this week we looked at the compensation incentives Mylan designed for senior executives—incentives that drove them to raise the price of EpiPens to punishing levels for consumers. Let’s keep pulling on that thread. It leads to some excellent questions…
Read MoreEpiPen Fiasco Shows Corporate America Like It Is
Start with this fact fixed in your mind before we begin talking about Mylan Labs and its EpiPen: a company’s stock price is determined by its future earnings growth. You can look up how corporate finance theorists reached that conclusion if you want. For our purposes here—which are to examine how Mylan landed in such…
Read More